Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Well Pharmaceutical is a leading Chinese manufacturer specializing in pharmaceutical excipients, synthetic lubricants, and health care chemicals. The company focuses on the research, development, and production of high-end excipients such as polyethylene glycols, poloxamers, and fatty acid esters. Their products are widely used in oral, topical, and injectable drug formulations to improve stability and delivery. As a publicly traded entity on the Shanghai Stock Exchange, Nanjing Well serves both domestic and international pharmaceutical markets with GMP-compliant manufacturing facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Well.